In our study, we found that Eomes expression was elevated in tumor-infiltrating CD8+ T cells as tumor progressed, and exhausted CD8+ TILs (characterized by co-expression of PD-1 and Tim-3) possessed enhanced expression of Eomes than naïve, memory and effector cells in tumor. The gene discussed is HAVCR2; the disease is neoplasm.